Human cytomegalovirus (HCMV) is a member of the virus family Herpesviridae. Human cytomegalovirus is prevalent in the population and can establish lifelong latency in the host. Latency is characterized by the absence of virion production and limited viral gene expression, with the ability to periodically reactivate virus replication [1] . In immunocompetent people, HCMV infection is generally asymptomatic, and the virus persists with little or no associated pathology. However, in immunocompromised individuals, such as AIDS patients and transplant recipients, reactivation of latent HCMV may cause life-threatening diseases [2, 3] .
One mechanism for facilitating virus persistence in the host is expression of genes that mimic host immune modulators, particularly cytokines and cytokine receptors. The UL111A gene of HCMV encodes a viral ortholog of cellular interleukin 10 (cIL-10). A pleiotropic cytokine, cIL-10 stimulates B-cell growth and promotes Th2 responses but is also essential for terminating inflammatory responses through suppression of Th1 cytokines and inhibition of immune effector cells [4] . The HCMV cytokine, cytomegalovirus interleukin 10 (cmvIL-10), is a 175-amino acid (AA) protein produced during lytic infection [5] [6] [7] . Despite having only 27% AA sequence identity to cIL-10, cmvIL-10 binds with high affinity to the cIL-10 receptor (IL-10R), triggering the same anti-inflammatory effects as cIL-10 [5, 8, 9] . cmvIL-10 activates transcription factor Stat3, inhibits peripheral blood mononuclear cell proliferation and inflammatory cytokine production, induces downregulation of class I and class II major histocompatibility complex molecules, impairs dendritic cell maturation, and also upregulates cIL-10 expression to further promote an immune-suppressive environment during infection (reviewed in McSharry et al [10] ).
The UL111A gene is comprised of 3 exons, and splicing of the 2 introns gives rise to a transcript that yields the 175-AA cmvIL-10 protein [5] . During latency, however, a second isoform is produced through alternative splicing of the UL111A gene, yielding latency-associated cmvIL-10 (LAcmvIL-10) [11] . The LAcmvIL-10 protein is identical to cmvIL-10 for the first 127 AAs but diverges in the last 12 AAs, resulting in a shorter 139-AA protein with a distinct C-terminus. LAcmvIL-10 has immune-suppressive functions and downregulates major histocompatibility complex class II expression on latently infected granulocyte macrophage progenitor cells and monocytes [12] . LAcmvIL-10 produced during latent infection is responsible for an increase in levels of monocyte-attracting chemokine CCL8/ MCP-2 through suppression of the cellular miRNA, hsa-miR92a [13] . However, LAcmvIL-10 lacks some IL-10R contact residues because of its truncated C-terminus and does not induce the full range of cmvIL-10 functions. Neither Stat3 phosphorylation nor inhibition of inflammatory cytokine synthesis has been observed in response to LAcmvIL-10 [12, 14] , suggesting the shorter isoform may exert a more limited set of cIL-10's functions to facilitate virus latency.
Initially identified as a latency factor, LAcmvIL-10 has also been detected during productive infection [7] . The specific roles of cmvIL-10 and LAcmvIL-10 (collectively vIL-10) during virus infection have been challenging to define. The 2 proteins have extensive sequence collinearity; thus the relative proportions of the 2 isoforms produced during infection remain unknown. In addition, it is difficult to study the role of vIL-10 in vivo because HCMV is highly species specific, and rodent CMVs lack an IL-10-like protein [15] . However, the rhesus CMV genome encodes an IL-10 ortholog, RhcmvIL-10, with immunosuppressive functions [6, 9] . Although no alternative or latency-associated isoforms of RhcmvIL-10 have been identified, neutralizing antibodies against RhcmvIL-10 are present in the serum of infected macaques, demonstrating that the viral cytokine is produced during natural infection [6] . Likewise, anticmvIL-10 specific antibodies have been reported in healthy, HCMV-seropositive adults [16] , suggesting that sufficient levels of vIL-10 are produced during infection to induce antibody responses. Because HCMV latently infects monocytes and myeloid progenitor cells [1, 17] and also periodically reactivates and productively infects many cell types in the human body, such as epithelial cells, endothelial cells, and fibroblasts, we hypothesized that vIL-10 could be detected in peripheral blood.
Other human herpesviruses express viral cytokines that have been detected systemically. Epstein-Barr virus (EBV) encodes ebvIL-10, a protein with 84% homology to cIL-10 that is expressed during lytic infection [18] , stimulates cIL-10 production [19] , and is detected in the peripheral blood of patients with acute mononucleosis [20] . Kaposi's sarcomaassociated herpesvirus (KSHV) encodes a vIL-6 that acts as a cellular growth factor [21] detected in plasma from patients with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman disease [22, 23] . Here, we used a sensitive and specific enzyme-linked immunosorbent assay (ELISA) to detect vIL-10 in plasma of HCMV + blood donors.
MATERIALS AND METHODS

Cells, Viruses, and Reagents
Neonatal foreskin fibroblasts (NuFF) were cultured in Dulbecco's modified Eagle's media with 10% fetal bovine serum in a humidified 37°C incubator with 5% carbon dioxide atmosphere. Human cytomegalovirus strain AD169 was used to infect NuFF cells. THP-1 monocytes were cultivated in complete Roswell Park Memorial Institute medium with 10% fetal bovine serum. Purified recombinant cmvIL-10, cIL-10, and ebvIL-10 were from R&D Systems. Purified recombinant LAcmvIL-10 was synthesized.
Human Blood Samples
Human blood samples in ethylenediaminetetraacetic acid tubes were from Blood Centers of the Pacific and Stanford Blood Bank. Whole blood was centrifuged at 1300 × g for 10 minutes at 4°C to obtain plasma. Where indicated, 500 µL of whole blood were removed for DNA extraction before plasma isolation.
Enzyme-Linked Immunosorbent Assay
Human cytomegalovirus serostatus was tested using HCMV immunoglobulin G (IgG) and immunoglobulin M (IgM) ELISA kits as directed. The IL-10 ELISA DuoSet was used to detect cIL-10 according to manufacturer's protocol with minor modifications: plates were coated at 4°C overnight, and the standard curve used 5-fold serial dilution for a range of 10 000-0.64 pg/mL. The HCMV vIL-10 ELISA was performed under the same conditions using anti-cmvIL-10 goat polyclonal antibody (AF117) for capture and biotinylated antibody (BAF117) at 0.2 µg/mL for detection [24] . Reagent diluent for the protein standard was phosphate-buffered saline (PBS) + 1% bovine serum albumin (BSA) for cell-culture samples or PBS + 10% HCMV − plasma with plasma samples. Supernatants were assayed undiluted; plasma was diluted to 10% in PBS. Concentrations were interpolated from the standard using a 5-parameter logistic curve fit and adjusted for dilution factor. Internal standards for vIL-10 and cIL-10 (500 pg/mL) were included for validation on all plates.
For the anti-vIL-10 IgG ELISA, plates were coated with 12.5 ng/well cmvIL-10 or glycoprotein B (gB) as previously described [25] . Plasma samples were heat-inactivated (56°C, 30 minutes) and tested diluted 1:100 in PBS + 1% BSA + 0.05% Tween. The threshold value for a positive result was set above the highest reading for any seronegative donor, as previously described [26] .
Western Blotting
Mock or AD169-infected NuFF cells (multiplicity of infection, MOI = 0.1, 96 hrs) were lysed as previously described [14] , separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose. The membrane was probed overnight at 4°C with heat-inactivated donor plasma in TBS-T + 5% milk (1:1000 dilution). Alkaline phosphatase (AP)-conjugated goat antihuman IgG (1:1000) and AP substrate were used to visualize bands. Purified recombinant proteins (20 µg in PBS) were mixed with loading dye, heated, and blotted as above using anti-cmvIL-10 goat polyclonal antiserum (AF117, 1:1000) and donkey antigoat-AP.
THP-1 cells were treated with 10 ng/mL of purified recombinant cmvIL-10 in a volume of 100 µL for 10 minutes at 37°C to induce Stat3 phosphorylation. Heat-inactivated plasma was added for 10 minutes before cmvIL-10 where indicated. After treatment, cells were lysed and separated by SDS-PAGE and immunoblotted. Antibodies against phospho-Stat3 or total Stat3 were used at 1:1000 dilution followed by goat antirabbit-AP (1:1000).
Polymerase Chain Reaction
Genomic DNA (gDNA) was extracted from whole blood using the ReliaPrep Blood gDNA MiniPrep System. Nested polymerase chain reaction (PCR) for exon 4 of HCMV IE1 was performed as described [27] using 500 ng of gDNA as template with gene-specific primers for IE1 5'-GGTCACTAGTGACGCTTGTATGATGAC-3' and 5'-GATAGTCGCGGGTACAGGGGACTCT-3' or β-actin 5'-AAGAGAGGCATCCTCACC-3' and 5'-TACATGGCTGGGTGTTG-3' with the following PCR program: 94°C, 5 minutes; then 35 cycles of 94°C, 30 seconds, 58°C, 30 seconds, 72°C, 1 minute. For IE1, a second round using 2 µL of initial reaction and nested primer pair 5'-AAGTGAGTTCTGTCGGGTGCT -3' and 5'GTGACACCAGAGAATCAGAGGA-3' was performed under the same conditions. pGEM-IE1 plasmid encoding exon 4 of IE1 was a positive control. Polymerase chain reaction products were visualized by agarose gel electrophoresis.
Statistical Analysis
SAS software was used for Mann-Whitney nonparametric test, Pearson's correlation coefficient, and associated P values for significance at .05 (2-tailed).
RESULTS
Antigenic distinction between cmvIL-10, LAcmvIL-10, and cIL-10
Using a well-established ELISA for detection of cmvIL-10 [24, 28] , we confirmed the assay also recognized LAcmvIL-10 without cross-reactivity to cIL-10. NuFF cells were infected with HCMV strain AD169, and vIL-10 was evident by day 4 with levels that increased as the infection progressed ( Figure  1A ). Supernatants were also tested for cIL-10, but the cellular cytokine was not produced by NuFFs at any point during infection. THP-1 monocytes exposed to lipopolysaccharide (LPS) for 24 hours produced cIL-10, but not vIL-10, and supernatants served as a positive control for cIL-10-containing culture medium ( Figure 1A ). These results demonstrate that the cellular and viral cytokines are antigenically distinct and do not exhibit cross-reactivity with the antibodies used in these detection assays.
Supernatants from infected cell cultures should contain a mixture of cmvIL-10 and LAcmvIL-10 [7] . To confirm that each individual protein was recognized by the vIL-10 assay, reagent diluent was spiked with 500 pg/mL of purified recombinant cmvIL-10, LAcmvIL-10, ebvIL-10, or cIL-10. The input cmvIL-10 and LAcmvIL-10 were accurately measured ( Figure 1B) , and neither ebvIL-10 nor cIL-10 was detected. Although cIL-10 was accurately measured by the cIL-10 assay, there was no detection of any of the viral cytokines ( Figure 1C ), even ebvIL-10, which has relatively high sequence identity to cIL-10. Antibodies specific for cIL-10 or ebvIL10 that do not cross-react have been reported [29] , so this result is not surprising. The appropriate cytokines were detected whether the reagent diluent was PBS + 1% BSA or PBS + 10% plasma. Western blotting further confirmed that only cmvIL-10 (evident as a 34-kD dimer) and LAcmvIL-10 (33-kD dimer and 16.8-kD monomer) were detected by the anti-cmvIL-10 antibody ( Figure 1D) . Thus, the vIL-10 ELISA is accurate for measurement of both cmvIL-10 and LAcmvIL-10 and does not cross-react with either cIL-10 or ebvIL-10.
Presence of vIL-10 in Peripheral Blood of Healthy Donors
To investigate whether vIL-10 could be detected in the peripheral blood of individuals infected with HCMV, plasma from local blood banks was first tested for reactivity to HCMV antigens by direct ELISA. Of 48 samples, 24 were positive for anti-HCMV IgG, indicating a current or previous infection ( Figure  2A) . Positive samples had an immune status ratio (ISR) >1.1, determined by a ratio of the optical density at 450 nm (OD 450) value to the calibration control. These results were consistent with HCMV serostatus information provided by the blood bank when the samples were acquired. Two additional samples designated HCMV IgG seropositive by the blood bank yielded ISR values in the equivocal range (0.9-1.1) in this assay, but given the blood bank results, these specimens were considered HCMV seropositive as well. All other specimen ISR values were well below the cutoff and considered negative for HCMV infection (n = 22). All 48 of the specimens tested below the cutoff for HCMV IgM, suggesting that none of the donors was experiencing primary infection or virus reactivation at levels sufficient to induce IgM production.
All plasma samples, whether HCMV IgG + or IgG − , were tested for both vIL-10 and cIL-10. The vIL-10 protein was detected in 19 of 26 specimens from HCMV + donors (Table 1, Fig. 2B ) but was generally undetectable in the HCMV − donors. HCMV + donors had higher levels of cIL-10 than seronegative donors, although this difference did not achieve statistical significance (Table 1, Figure 2C ). The mean age of the HCMV + and HCMV − groups were not significantly different ( Table 1 ), suggesting that donor age did not influence cytokine level. This observation is consistent with published reports indicating that plasma levels of cIL-10 are not affected by age [30, 31] , and there was no significant correlation between age and either vIL-10 or cIL-10 level. Among HCMV + donors, there was a positive correlation between vIL-10 and cIL-10 levels ( Table 2 ), suggesting that vIL-10 may have some influence on levels of cIL-10 in the human host. In culture, vIL-10 has been shown to promote expression of cIL-10 by monocytes, dendritic cells, B cells, and CD4 + T cells [13, 14, 24, 32, 33] . In addition, there was a statistically significant negative correlation between cIL-10 levels and HCMV IgG ISR (P < .02) ( Table 2 ), which could indicate that reduced humoral responses enable greater virus activity and thus higher cIL-10 levels.
Anti-vIL-10 Antibodies in Donors With vIL-10
The anti-HCMV IgG assay evaluates immune response to antigens found in the virus particle; however, vIL-10 is a secreted protein released from infected cells and thus not represented as an antigen in this test. Because many donors showed evidence of vIL-10 protein in their peripheral blood, we investigated whether these donors might also have anti-vIL-10 antibody responses. Purified recombinant cmvIL-10 protein was used as antigen in a direct ELISA, and heat-inactivated donor plasma was tested for reactivity ( Figure 3A) . Overall, seropositive donors had higher OD 450 readings than seronegative donors, and this difference was significant when compared via Mann-Whitney test (P < .001).
A cutoff value was established using the highest reading for any seronegative donor, and six seropositive donors had OD 450 values above the cutoff (23% of HCMV + donors), consistent with a previous report finding anti-cmvIL-10 responses in 28% of HCMV + donors [16] . For comparison, a purified immunodominant segment of gB protein was also used as coating antigen, and anti-gB responses were identified in 12 of 26 donors ( Figure 3B ), although this number might be higher with a more complete gB protein segment. No significant correlations were observed between HCMV IgG ISR and anti-vIL-10 or anti-gB ODs ( Table 2 ), suggesting that the humoral responses to these specific antigens are not representative of the overall antiviral response measured in the commercial assay. One representative HCMV + donor (18187) and one representative HCMV − donor (20841) were tested for recognition of viral proteins from infected cells. Plasma was diluted 1:1000 and used to probe membranes containing cell lysates from mock or HCMV-infected NuFF cells. The HCMV + plasma from donor 18187 reacted strongly with multiple bands in the infected cell lysate, whereas the HCMV − plasma reacted only weakly with a few bands that were also present in the mock-infected cells ( Figure 3C ). Taken together, these results demonstrate that plasma from HCMV + donors recognizes a broad range of viral antigens, including vIL-10.
Plasma from the 6 donors with anti-vIL-10 antibody responses was further tested to determine whether these antibodies could neutralize vIL-10 activity. THP-1 cells were treated with purified cmvIL-10 in the presence or absence of the donor plasma and then phosphorylation of Stat3 was examined by Western blot. Stat3 rapidly becomes phosphorylated in the presence of cmvIL-10, so this is a robust measure of cmvIL-10 activity [14, [34] [35] [36] . Stat3 phosphorylation was evident when cells were exposed to cmvIL-10, but plasma from donor 18187 was able to completely block this effect, indicating that neutralizing antibodies were present ( Figure 3D ). Including donor 18187, only 3 of the 6 donors Abbreviations: cIL-10, human cellular interleukin 10; gB, glycoprotein B; HCMV, human cytomegalovirus; IgG, immunoglobulin G; ISR, immune status ratio; OD, optical density; vIL-10, viral interleukin 10.
a Immune status ratio was determined by dividing specimen optical density value by the cutoff calibrator value according to manufacturer's instructions.
b Optical density value at 450 nm.
with anti-vIL-10 antibodies (50%) were found to have vIL-10-neutralizing antibodies, as measured by the ability to block Stat3 phosphorylation here. Interestingly, for the donors with anti-vIL-10 antibody responses, there was a strongly positive correlation between anti-vIL-10 OD and vIL-10 concentration that was statistically significant (R = 0.84; P < .05) ( Table 3 ). These results suggest that individuals who have more vIL-10 in circulation develop greater antibody responses to the viral cytokines.
Viral DNA in Seronegative Donors
Although vIL-10 was detected in many HCMV + donors, we also found vIL-10 in a small subset of HCMV − donors. Because it is well documented that some HCMV − individuals are positive for viral DNA by PCR [11, 27, 37, 38] , we investigated whether these seronegative donors might harbor HCMV. Polymerase chain reaction was performed on genomic DNA for the immediate early 1 (IE1) gene of HCMV, a widely used marker for the presence of viral genomes [27] . IE1 was detected in all 4 HCMV + donors, as well as in 2 HCMV − donors with detectable vIL-10 ( Figure 4) .
DISCUSSION
This study demonstrates that HCMV cytokines can be detected in peripheral blood during natural infection. Although other herpesviruses encode cytokines found systemically in infected individuals, EBV and KSHV cytokines are associated with acute disease [20, 22, 23, 39] . Human cytomegalovirus is the only herpesvirus that expresses a viral cytokine during latency, and our results are novel because HCMV vIL-10 was detected in healthy individuals with no overt signs of disease. This suggests that HCMV exerts considerably significant influence on the host immune environment. The presence of an immune-suppressive viral cytokine at systemic levels may enhance tolerance of the virus in the body. The ability to detect and measure vIL-10 levels is expected to reveal new insights into how HCMV manipulates the host immune functions to facilitate lifelong persistence. Herpesviruses coevolve with their specific hosts, and notably, HCMV is the only virus known to express 2 isoforms of vIL-10. The expression of each UL111A transcript can be independently regulated, with both forms expressed in productive infection but only LAcmvIL-10 expressed during latency [7, 11] . Because 2 two proteins share the same sequence for 127 AAs, both cmvIL-10 and LAcmvIL-10 are recognized equally well in our assay. The specimens examined here were from healthy donors, who could be experiencing either true latent infection or low-level lytic infection, so it is difficult to say which isoform(s) we detected here. It is tempting to speculate that HCMV has evolved the truncated LAcmvIL-10 isoform to induce a specific, limited subset of immune suppressive functions for the maintenance of latency, without broadly compromising the immune function or overall health of the host. LAcmvIL-10 may enable the virus to make precision adjustments in the level of immune responsiveness, while retaining the option to more drastically impair immune responses if needed through expression of cmvIL-10 and also by inducing cIL-10. Indeed, we cannot presently rule out the possibility that cmvIL-10 is also found in the peripheral blood. The specific factors that govern the regulation and splicing of UL111A gene expression remain to be determined, and UL111A expression may be leaky, and some full-length cmvIL-10 may be produced. Future work is necessary to develop reagents that distinguish between cmvIL-10 and LAcmvIL-10 to discern specific roles of each protein during virus infection.
In addition to the isoform of vIL-10, genetic polymorphisms can influence responses to cytokine signaling. In a study of AIDS patients, a specific haplotype conveying an AA substitution in the cytoplasmic domain of the IL-10R1 gene was found to protect against the development of HCMV retinitis [40] . These individuals might be less affected by the activity of vIL-10, which is supported by the previous observation that common IL-10R1 variants rs3135932 (SNP3) and rs2229113 (SNP4) reduce signaling by cmvIL-10 [35] . Likewise, an IL-10R1 haplotype with a single AA substitution in the extracellular domain (I122V) occurred with higher frequency in HCMV retinitis patients [40] , indicating that this change might actually enhance vIL-10 signaling outcomes to promote disease.
We did not detect vIL-10 in every HCMV + donor tested. These individuals may produce vIL-10 at levels below the limit of detection, or they could be infected with strains of HCMV that do not express vIL-10. Although we were unable to perform deep sequencing on these samples, laboratories that routinely sequence HCMV have noted that the UL111A gene is among the more frequently mutated [41, 42] , which could result in reduced or no protein expression. Viral mutants lacking UL111A are replication competent and exhibit no significant defects in establishing or reactivating from latency in vitro [43] . Additional future investigations will include the examination of a larger number of samples on which DNA sequencing and serological analysis can be performed. Surprisingly, vIL-10 was detected in some HCMV − donors. Several groups have reported viral DNA in seronegative donors [11, 27, 37, 38, 44] . Transfusion-transmitted HCMV infections have been documented, particularly after cardiac surgery [45, 46] , but leukoreduction of transfused blood is now standard and greatly reduces risk to susceptible populations because monocytes are the primary reservoir for HCMV in the blood. Still, evidence of HCMV infection in individuals without apparent antibody response continues to mount, with IE1-specific T-cell responses recently reported in a small percentage of HCMV − women [47] . Human cytomegalovirus has evolved extensive immunomodulatory abilities, and subversion of antibody responses could be more successful in certain hosts.
Although detection of nucleic acid can be more sensitive than serology for indicating the presence of HCMV, measurements of viral load have been problematic for disease diagnosis, particularly in transplantation, because viremia can be associated with HCMV disease or with asymptomatic shedding [48, 49] . vIL-10 may be an alternative measure of viral activity that could help predict risk of HCMV disease in transplant recipients. As with other immunosuppressive cytokines, elevated levels of vIL-10 could indicate progression to a diseased state. By quantifying vIL-10 levels in healthy, asymptomatic blood donors, this study has laid the groundwork for investigating vIL-10 levels during latent and lytic infection and could potentially provide a useful tool for investigating progression to disease.
Notes
